Skip to main content

Advertisement

SpringerLink
Log in

Aging, fat mass, and prostate cancer: is it the time to reconsider testosterone?

  • Point of View
  • Published:
Aging Clinical and Experimental Research Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Bhaskaran K, Douglas I, Forbes H et al (2014) Body-mass index and risk of 22 specific cancers: a population-based cohort study of 5.24 million UK adults. Lancet 384:755–765. https://doi.org/10.1016/s0140-6736(14)60892-8

    Article  PubMed  PubMed Central  Google Scholar 

  2. Di Vincenzo A, Silvestrin V, Bertoli E et al (2018) Short-term effects of surgical weight loss after sleeve gastrectomy on sex steroids plasma levels and PSA concentration in men with severe obesity. Aging Male 17:1–5. https://doi.org/10.1080/13685538.2018.1528445

    Article  CAS  Google Scholar 

  3. Gómez-Gómez E, Carrasco-Valiente J, Campos-Hernández JP et al (2019) Clinical association of metabolic syndrome, C-reactive protein and testosterone levels with clinically significant prostate cancer. J Cell Mol Med 23:934–942. https://doi.org/10.1111/jcmm.13994

    Article  CAS  PubMed  Google Scholar 

  4. Duarte MF, Luis C, Baylina P et al (2018) Clinical and metabolic implications of obesity in prostate cancer: Is testosterone a missing link? Aging Male 24:1–13. https://doi.org/10.1080/13685538.2018.1519695

    Article  CAS  Google Scholar 

  5. Yassin A, Salman M, Talib RA et al (2017) Is there a protective role of testosterone against high-grade prostate cancer? Incidence and severity of prostate cancer in 553 patients who underwent prostate biopsy: a prospective data register. Aging Male 20:125–133. https://doi.org/10.1080/13685538.2017.1298584

    Article  CAS  PubMed  Google Scholar 

  6. Zhang X, Zhong Y, Saad F et al (2019) Testosterone therapy may reduce prostate cancer risk due to testosterone deficiency at a young age via stabilizing serum testosterone levels. Aging Male 12:1–7. https://doi.org/10.1080/13685538.2019.1578739

    Article  Google Scholar 

  7. Haider A, Zitzmann M, Doros G et al (2015) Incidence of prostate cancer in hypogonadal men receiving testosterone therapy: observations from 5-year median followup of 3 registries. J Urol 193:80–86. https://doi.org/10.1016/j.juro.2014.06.071

    Article  PubMed  Google Scholar 

  8. Kardoust Parizi M, Abufaraj M, Fajkovic H et al (2019) Oncological safety of testosterone replacement therapy in prostate cancer survivors after definitive local therapy: a systematic literature review and meta-analysis. Urol Oncol pii: S1078–1439:30236–30244. https://doi.org/10.1016/j.urolonc.2019.06.007

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Clinica Medica 3, Department of Medicine – DIMED, University-Hospital of Padova, Via Giustiniani 2, 35128, Padua, Italy

    Angelo Di Vincenzo, Hamza El Hadi, Roberto Vettor & Marco Rossato

Authors
  1. Angelo Di Vincenzo
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Hamza El Hadi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Roberto Vettor
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Marco Rossato
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Angelo Di Vincenzo.

Ethics declarations

Conflict of interest

The authors declare that they have no competing interests.

Ethical statement

This article does not contain any studies with human participants or animals.

Informed consent

Informed consent does not apply to this submission.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Di Vincenzo, A., El Hadi, H., Vettor, R. et al. Aging, fat mass, and prostate cancer: is it the time to reconsider testosterone?. Aging Clin Exp Res 32, 357–359 (2020). https://doi.org/10.1007/s40520-019-01372-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40520-019-01372-7

Search

Navigation